ALK execs rake in profits after exercising share options
Several of the top leaders at ALK utilized their share options at the start of this week, gaining shares in the firm that they have since sold for million-kroner profits.
by marketwire, translated by catherine brett
At the start of this week, several of the top managers at allergy firm ALK exercised their rights to buy shares in the company. They have since sold these shares again, resulting in substantial profits, an internal memo reveals.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK CEO misses bonus target for fifth year in a row
For subscribers
.jpg)
.jpg&w=384&q=75)
